Investors are more wary of mRNA vaccine funding than ever

Plus: Eli Lilly says it will raise drug prices in Europe to "make them lower" in U.S.

August 14, 2025 Check out STAT+

Sponsored By

STAT just won four Edward R. Murrow Awards! The prizes are among the most prestigious in American journalism, celebrating work that serves the public interest and has a measurable impact. Read the stories being celebrated here.

Adobe STAT+ | Eli Lilly says it will raise drug prices in Europe to 'make them lower' in U.S. The move could gain favor in the White House, but the impact on patients in U.S. and overseas remains unclear. By Elaine Chen and Daniel Payne STAT+ | Trump administration leaves biotech investors more wary than ever of funding mRNA vaccines Life science investors say the Trump administration's retreat from mRNA vaccine funding is creating uncertainty for biotech firms. By Jonathan Wosen and Allison DeAngelis STAT+ | MIT president Sally Kornbluth responds to Globe report on academic fraud case at Duke Kornbluth responded to a report detailing her time as an administrator at Duke amid a cancer research scandal more than a decade ago. By Nick Stoico — Boston Globe Adobe STAT+ | Drugmakers form new group to lobby on impact of Medicare drug price negotiations The members of IRA Watchdog are Merck, AstraZeneca, Bristol Myers Squibb Company, and Eli Lilly, according to lobbying disclosure records. By John Wilkerson Lowering blood pressure reduces dementia risk, new guideline affirms American Heart Association and American College of Cardiology add dementia to high blood pressure risk list along with heart, kidney disease. By Elizabeth Cooney STAT+ | U.S. warning on use of 'march-in' rights against Harvard seems like distant threat for pharma Commerce Secretary Howard Lutnick's threat of march-in rights against Harvard University has put renewed focus on the Bayh-Dole Act. By Ed Silverman Adobe Can a computer turn our internal monologue into speech? Stanford researchers have decoded inner speech, a step toward brain-computer interfaces helping people with paralysis communicate By O. Rose Broderick

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser